Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Cohance Lifesciences Ltd.
NSE: COHANCE
|
BSE: 543064
|
ISIN: INE03QK01018
|
Industry: Pharmaceuticals
|
Expensive Underperformer
306.1500
9.85
(
3.32
%)
NSE
Mar 25, 2026
15:31 PM
75.51% Fall from 52W High
Volume:
644.6K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Cohance Lifesciences Ltd.
20 May 2022
306.15
3.32%
SUVEN PHARMACEUTICALS LIMITED
Accumulate:
Cohance Lifesciences Ltd.
by
Geojit BNP Paribas
Target: 602
Recommendation
Target
Geojit BNP Paribas
Cohance Lifesciences has lost
-73.96%
in the last 1 Year
More from Cohance Lifesciences Ltd.
Recommended
Between Swiggy and Zomato, Swiggy takes the dark patterns crown
The Baseline |
25 Mar 2026, 06:40PM
Market closes higher as the US seeks a month-long ceasefire in the Iran war
Trendlyne Marketwatch |
25 Mar 2026, 04:12PM
Five stocks to buy from analysts this week - March 24, 2026
The Baseline |
24 Mar 2026, 05:46PM